share_log

Alliance Global Partners Maintains Buy on Tonix Pharmaceuticals, Raises Price Target to $11

Benzinga ·  Jul 22 11:59  · Ratings

Alliance Global Partners analyst James Molloy maintains Tonix Pharmaceuticals (NASDAQ:TNXP) with a Buy and raises the price target from $6 to $11.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment